361 related articles for article (PubMed ID: 26697201)
1. Implications of mismatch repair-deficient status on management of early stage colorectal cancer.
Kawakami H; Zaanan A; Sinicrope FA
J Gastrointest Oncol; 2015 Dec; 6(6):676-84. PubMed ID: 26697201
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability testing and its role in the management of colorectal cancer.
Kawakami H; Zaanan A; Sinicrope FA
Curr Treat Options Oncol; 2015 Jul; 16(7):30. PubMed ID: 26031544
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
[TBL] [Abstract][Full Text] [Related]
4. The impact of microsatellite stability status in colorectal cancer.
Gupta R; Sinha S; Paul RN
Curr Probl Cancer; 2018 Nov; 42(6):548-559. PubMed ID: 30119911
[TBL] [Abstract][Full Text] [Related]
5. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
6. Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer.
Zeinalian M; Hashemzadeh-Chaleshtori M; Salehi R; Emami MH
Adv Biomed Res; 2018; 7():28. PubMed ID: 29531926
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
8. Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the Mismatched.
Tsai CY; Lin TA; Huang SC; Hsu JT; Yeh CN; Chen TC; Chiu CT; Chen JS; Yeh TS
Oncologist; 2020 Jul; 25(7):e1021-e1030. PubMed ID: 32058649
[TBL] [Abstract][Full Text] [Related]
9. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
10. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in
Zaanan A; Bachet JB; André T; Sinicrope FA
Curr Colorectal Cancer Rep; 2014 Sep; 10(3):346-353. PubMed ID: 25386108
[TBL] [Abstract][Full Text] [Related]
12. The evolving role of microsatellite instability in colorectal cancer: A review.
Gelsomino F; Barbolini M; Spallanzani A; Pugliese G; Cascinu S
Cancer Treat Rev; 2016 Dec; 51():19-26. PubMed ID: 27838401
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of microsatellite instability in colorectal cancer.
de la Chapelle A; Hampel H
J Clin Oncol; 2010 Jul; 28(20):3380-7. PubMed ID: 20516444
[TBL] [Abstract][Full Text] [Related]
14. The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing.
Ryan E; Sheahan K; Creavin B; Mohan HM; Winter DC
Crit Rev Oncol Hematol; 2017 Aug; 116():38-57. PubMed ID: 28693799
[TBL] [Abstract][Full Text] [Related]
15. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.
Sahnane N; Magnoli F; Bernasconi B; Tibiletti MG; Romualdi C; Pedroni M; Ponz de Leon M; Magnani G; Reggiani-Bonetti L; Bertario L; Signoroni S; Capella C; Sessa F; Furlan D;
Clin Epigenetics; 2015; 7():131. PubMed ID: 26697123
[TBL] [Abstract][Full Text] [Related]
16. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.
Parsons MT; Buchanan DD; Thompson B; Young JP; Spurdle AB
J Med Genet; 2012 Mar; 49(3):151-7. PubMed ID: 22368298
[TBL] [Abstract][Full Text] [Related]
17. Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population.
Yan WY; Hu J; Xie L; Cheng L; Yang M; Li L; Shi J; Liu BR; Qian XP
Onco Targets Ther; 2016; 9():7415-7424. PubMed ID: 27994472
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive significance of microsatellite instability in stage II colorectal carcinoma: An 8-year study from a tertiary center in South India.
Paulose RR; Ail DA; Biradar S; Vasudevan A; Sundaram KR
Indian J Cancer; 2019; 56(4):302-308. PubMed ID: 31607697
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive impact of DNA mismatch repair in the management of colorectal cancer.
Sinicrope FA; Yang ZJ
Future Oncol; 2011 Mar; 7(3):467-74. PubMed ID: 21417908
[TBL] [Abstract][Full Text] [Related]
20. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
